首页 | 本学科首页   官方微博 | 高级检索  
     

抗血小板治疗的最新进展
引用本文:蔡琳,邓晓奇,燕纯伯. 抗血小板治疗的最新进展[J]. 心血管病学进展, 2009, 30(1): 102-105
作者姓名:蔡琳  邓晓奇  燕纯伯
作者单位:成都市第三人民医院成都市心血管病研究所,四川,成都610031
摘    要:大量临床研究已证实抗血小板药物:阿司匹林、噻吩吡啶类药物、血小板膜糖蛋白受体桔抗剂、西洛他唑等在预防和治疗心脑血管疾病以及外周动脉血管病变中具有十分重要的作用。洞悉药物的作用机理、应用现状、进展和存在的争议,对于更好地运用该类药物具有十分重要的作用。现就相关内容进行简要综述。

关 键 词:抗血小板药物  阿司匹林  噻吩吡啶类药  血小板膜糖蛋白受体拮抗剂  西洛他唑  普拉格雷

The Latest Progress of Antiplatelet Therapy
CAI Lin,DENG Xiao-qi,YAN Chun-bo. The Latest Progress of Antiplatelet Therapy[J]. Advances in Cardiovascular Diseases, 2009, 30(1): 102-105
Authors:CAI Lin  DENG Xiao-qi  YAN Chun-bo
Affiliation:CAI Lin, DENG Xiao-qi, YAN Chun-bo ( Chengdu Cardiovascular Disease Institute, The Third People's Hospital of Chengdu, Chengdu 610031, China)
Abstract:Many clinical studies have confirmed that antiplatelet drugs act important roles to prevent and treat the cardiac disease, cerebrovascular disease and peripherial artery disease, such as aspirin, thienopyridine, GPⅡ b/ Ⅲa receptor antagonist, cilostazol and so on. In order to make use of these drugs better, it is very important that to know clearly their mechanism of action, the current situation of application, advancement and the dispute. This article provides an overview on these questions.
Keywords:antiplatelet drugs  aspirin  thienopyridine  GP Ⅱ b/ Ⅲ a receptor antagonist  cilostazol  prasugrel
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号